Difference between revisions of "Part:BBa K103018:Experience"
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | This experience page is provided so that any user may enter their experience using this part.<BR>Please enter | ||
Line 6: | Line 5: | ||
===Applications of BBa_K103018=== | ===Applications of BBa_K103018=== | ||
− | === | + | ==='Hunter and prey' selection system=== |
<!-- DON'T DELETE --><partinfo>BBa_K103018 StartReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K103018 StartReviews</partinfo> | ||
− | <!-- Template for a user review | + | <!-- Template for a user review --> |
{|width='80%' style='border:1px solid gray' | {|width='80%' style='border:1px solid gray' | ||
|- | |- | ||
|width='10%'| | |width='10%'| | ||
− | <partinfo>BBa_K103018 AddReview | + | <partinfo>BBa_K103018 AddReview 5</partinfo> |
− | <I> | + | <I>Keton</I> |
|width='60%' valign='top'| | |width='60%' valign='top'| | ||
− | + | We have used this part in fusion with [[Part:BBa_K103003 | BBa_K103003]] and [[Part:BBa_K103004 | BBa_K103004]] to create hunter expression devices: | |
+ | *OmpA_omega_A (compatible prey: His_alpha_Z - fusion of [[Part:BBa_K103019 | BBa_K103019]] with [[Part:BBa_K103004 | BBa_K103004]]) | ||
+ | *OmpA_omega_Z (compatible prey: His_alpha_A - fusion of [[Part:BBa_K103019 | BBa_K103019]] with [[Part:BBa_K103003 | BBa_K103003]]) | ||
+ | *OmpA_omega negative control device without hunter [[Part:BBa_K103018 | BBa_K103018]] | ||
+ | *OmpA_omega_A_alpha positive control device containing both beta-lactamase halves [[Part:BBa_K103018 | BBa_K103018]] in fusion with [[Part:BBa_K103003 | BBa_K103003]] and [[Part:BBa_K103008 | BBa_K103008]] | ||
+ | |||
+ | To check optimal IPTG and ampicilin concentrations we have used OmpA_omega_A_alpha positive control device which should make cells ampicilin resistant. We have obtained following results: | ||
+ | {| style='border:1px solid gray; border-collapse: collapse;' | ||
+ | ! colspan="7" style='border:1px solid gray; border-collapse: collapse;' | OD<sub>600</sub> of Top10 cultures expressing OmpA_omega_A_alpha | ||
+ | |- | ||
+ | ! rowspan="2" valign="top" style='border:1px solid gray; border-collapse: collapse;' | Ampicilin concentration (ug /ml) | ||
+ | ! colspan="6" style='border:1px solid gray; border-collapse: collapse;' | IPTG Concentration (uM) | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0.1 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0.25 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0.5 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0.75 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 1 | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 25 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 1.054 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 1.154 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 1.051 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.99 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 1.096 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.896 | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 50 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.94 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.891 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 1.123 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.847 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.924 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0,81 | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 75 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.5 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.63 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.743 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.782 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.631 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.64 | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 100 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.02 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.396 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.563 | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | 0.678 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.602 | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | 0.611 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | We have used 100 ug/ml ampicillin and 0.5 uM IPTG for further experiments. | ||
+ | |||
+ | To check if our hunter expression devices work we have tested growth of hunter expressing strains in liquid LB + Ampicillin + IPTG suplemented with His_alpha_A (compatible with OmpA_omega_Z hunter) and His_alpha_Z (compatible with OmpA_omega_A) prey proteins. | ||
+ | |||
+ | Following results were obtained: | ||
+ | |||
+ | {| style='border:1px solid gray; border-collapse: collapse;' | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Hunter variant | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Prey variant | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Growth with prey | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Growth without prey | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | OmpA_omega | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_alpha_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | OmpA_omega | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_A | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_alpha_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_A | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_alpha_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | - | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_A_alpha | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_omega_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | |- | ||
+ | ! style='border:1px solid gray; border-collapse: collapse;' | Omp_omega_A_alpha | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | His_alpha_Z | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | | style='border:1px solid gray; border-collapse: collapse;' | + | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | Addition of compatible prey to the culture medium makes hunter expressing cells survive. Unfortunately there are also false positives (Omp_omega_Z grows on medium containing His_omega_Z). This may be caused by ability of Z<sub>spa-1</sub> protein to form autoaggregates. | ||
+ | |||
+ | Concurrence tests were the next step in testing hunter and prey system. Two or more bacterial strains were mixed and added to medium with prey. The culture was incubated overnight and plasmid miniprep was prepared. The strains which survived were determined using restriction digests and PCR. Results were very good: in all cases strains encoding strongest interacting hunters always dominate the culture and are detectable both by PCR and restriction digests. The DNA yield from other strains was very small and can be detected only by PCR. | ||
+ | |||
+ | Conclusion: hunter and prey system works as expected allowing efficient selection of strain expressing the strongest interactor of a given protein. | ||
|}; | |}; | ||
<!-- End of the user review template --> | <!-- End of the user review template --> | ||
<!-- DON'T DELETE --><partinfo>BBa_K103018 EndReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K103018 EndReviews</partinfo> |
Revision as of 12:50, 25 October 2008
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K103018
'Hunter and prey' selection system
UNIQfc98a2bba40bfdaf-partinfo-00000000-QINU
•••••
Keton |
We have used this part in fusion with BBa_K103003 and BBa_K103004 to create hunter expression devices:
To check optimal IPTG and ampicilin concentrations we have used OmpA_omega_A_alpha positive control device which should make cells ampicilin resistant. We have obtained following results:
We have used 100 ug/ml ampicillin and 0.5 uM IPTG for further experiments. To check if our hunter expression devices work we have tested growth of hunter expressing strains in liquid LB + Ampicillin + IPTG suplemented with His_alpha_A (compatible with OmpA_omega_Z hunter) and His_alpha_Z (compatible with OmpA_omega_A) prey proteins. Following results were obtained:
Addition of compatible prey to the culture medium makes hunter expressing cells survive. Unfortunately there are also false positives (Omp_omega_Z grows on medium containing His_omega_Z). This may be caused by ability of Zspa-1 protein to form autoaggregates. Concurrence tests were the next step in testing hunter and prey system. Two or more bacterial strains were mixed and added to medium with prey. The culture was incubated overnight and plasmid miniprep was prepared. The strains which survived were determined using restriction digests and PCR. Results were very good: in all cases strains encoding strongest interacting hunters always dominate the culture and are detectable both by PCR and restriction digests. The DNA yield from other strains was very small and can be detected only by PCR. Conclusion: hunter and prey system works as expected allowing efficient selection of strain expressing the strongest interactor of a given protein. |
UNIQfc98a2bba40bfdaf-partinfo-00000002-QINU